CHMP approves Finox infertility biosimilar
This article was originally published in Scrip
Executive Summary
Swiss firm Finox Biotech has been given the green light by the European Medicines Agency's scientific committee for its biosimilar hormone drug to be approved in Europe as a treatment for infertility.